1 Iodine-containing Contrast Medium Market Overview
1.1 Product Overview and Scope of Iodine-containing Contrast Medium
1.2 Iodine-containing Contrast Medium Segment by Type
1.2.1 Global Iodine-containing Contrast Medium Market Value Comparison by Type (2023-2029)
1.2.2 Iohexol
1.2.3 Iodixanol
1.2.4 Iopamidol
1.2.5 Ioversol
1.2.6 Others
1.3 Iodine-containing Contrast Medium Segment by Application
1.3.1 Global Iodine-containing Contrast Medium Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Iodine-containing Contrast Medium Market Size Estimates and Forecasts
1.4.1 Global Iodine-containing Contrast Medium Revenue 2018-2029
1.4.2 Global Iodine-containing Contrast Medium Sales 2018-2029
1.4.3 Global Iodine-containing Contrast Medium Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Iodine-containing Contrast Medium Market Competition by Manufacturers
2.1 Global Iodine-containing Contrast Medium Sales Market Share by Manufacturers (2018-2023)
2.2 Global Iodine-containing Contrast Medium Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Iodine-containing Contrast Medium Average Price by Manufacturers (2018-2023)
2.4 Global Iodine-containing Contrast Medium Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Iodine-containing Contrast Medium, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Iodine-containing Contrast Medium, Product Type & Application
2.7 Iodine-containing Contrast Medium Market Competitive Situation and Trends
2.7.1 Iodine-containing Contrast Medium Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Iodine-containing Contrast Medium Players Market Share by Revenue
2.7.3 Global Iodine-containing Contrast Medium Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Iodine-containing Contrast Medium Retrospective Market Scenario by Region
3.1 Global Iodine-containing Contrast Medium Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Iodine-containing Contrast Medium Global Iodine-containing Contrast Medium Sales by Region: 2018-2029
3.2.1 Global Iodine-containing Contrast Medium Sales by Region: 2018-2023
3.2.2 Global Iodine-containing Contrast Medium Sales by Region: 2024-2029
3.3 Global Iodine-containing Contrast Medium Global Iodine-containing Contrast Medium Revenue by Region: 2018-2029
3.3.1 Global Iodine-containing Contrast Medium Revenue by Region: 2018-2023
3.3.2 Global Iodine-containing Contrast Medium Revenue by Region: 2024-2029
3.4 North America Iodine-containing Contrast Medium Market Facts & Figures by Country
3.4.1 North America Iodine-containing Contrast Medium Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Iodine-containing Contrast Medium Sales by Country (2018-2029)
3.4.3 North America Iodine-containing Contrast Medium Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Iodine-containing Contrast Medium Market Facts & Figures by Country
3.5.1 Europe Iodine-containing Contrast Medium Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Iodine-containing Contrast Medium Sales by Country (2018-2029)
3.5.3 Europe Iodine-containing Contrast Medium Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Iodine-containing Contrast Medium Market Facts & Figures by Country
3.6.1 Asia Pacific Iodine-containing Contrast Medium Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Iodine-containing Contrast Medium Sales by Country (2018-2029)
3.6.3 Asia Pacific Iodine-containing Contrast Medium Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Iodine-containing Contrast Medium Market Facts & Figures by Country
3.7.1 Latin America Iodine-containing Contrast Medium Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Iodine-containing Contrast Medium Sales by Country (2018-2029)
3.7.3 Latin America Iodine-containing Contrast Medium Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Iodine-containing Contrast Medium Market Facts & Figures by Country
3.8.1 Middle East and Africa Iodine-containing Contrast Medium Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Iodine-containing Contrast Medium Sales by Country (2018-2029)
3.8.3 Middle East and Africa Iodine-containing Contrast Medium Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Iodine-containing Contrast Medium Sales by Type (2018-2029)
4.1.1 Global Iodine-containing Contrast Medium Sales by Type (2018-2023)
4.1.2 Global Iodine-containing Contrast Medium Sales by Type (2024-2029)
4.1.3 Global Iodine-containing Contrast Medium Sales Market Share by Type (2018-2029)
4.2 Global Iodine-containing Contrast Medium Revenue by Type (2018-2029)
4.2.1 Global Iodine-containing Contrast Medium Revenue by Type (2018-2023)
4.2.2 Global Iodine-containing Contrast Medium Revenue by Type (2024-2029)
4.2.3 Global Iodine-containing Contrast Medium Revenue Market Share by Type (2018-2029)
4.3 Global Iodine-containing Contrast Medium Price by Type (2018-2029)
5 Segment by Application
5.1 Global Iodine-containing Contrast Medium Sales by Application (2018-2029)
5.1.1 Global Iodine-containing Contrast Medium Sales by Application (2018-2023)
5.1.2 Global Iodine-containing Contrast Medium Sales by Application (2024-2029)
5.1.3 Global Iodine-containing Contrast Medium Sales Market Share by Application (2018-2029)
5.2 Global Iodine-containing Contrast Medium Revenue by Application (2018-2029)
5.2.1 Global Iodine-containing Contrast Medium Revenue by Application (2018-2023)
5.2.2 Global Iodine-containing Contrast Medium Revenue by Application (2024-2029)
5.2.3 Global Iodine-containing Contrast Medium Revenue Market Share by Application (2018-2029)
5.3 Global Iodine-containing Contrast Medium Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GE Healthcare Iodine-containing Contrast Medium Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bayer Iodine-containing Contrast Medium Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Bracco Imaging
6.3.1 Bracco Imaging Corporation Information
6.3.2 Bracco Imaging Description and Business Overview
6.3.3 Bracco Imaging Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bracco Imaging Iodine-containing Contrast Medium Product Portfolio
6.3.5 Bracco Imaging Recent Developments/Updates
6.4 Guerbet Group
6.4.1 Guerbet Group Corporation Information
6.4.2 Guerbet Group Description and Business Overview
6.4.3 Guerbet Group Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Guerbet Group Iodine-containing Contrast Medium Product Portfolio
6.4.5 Guerbet Group Recent Developments/Updates
6.5 Hengrui Medicine
6.5.1 Hengrui Medicine Corporation Information
6.5.2 Hengrui Medicine Description and Business Overview
6.5.3 Hengrui Medicine Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Hengrui Medicine Iodine-containing Contrast Medium Product Portfolio
6.5.5 Hengrui Medicine Recent Developments/Updates
6.6 Lantheus
6.6.1 Lantheus Corporation Information
6.6.2 Lantheus Description and Business Overview
6.6.3 Lantheus Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Lantheus Iodine-containing Contrast Medium Product Portfolio
6.6.5 Lantheus Recent Developments/Updates
6.7 Sanochemia
6.6.1 Sanochemia Corporation Information
6.6.2 Sanochemia Description and Business Overview
6.6.3 Sanochemia Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sanochemia Iodine-containing Contrast Medium Product Portfolio
6.7.5 Sanochemia Recent Developments/Updates
6.8 Tyco Healthcare
6.8.1 Tyco Healthcare Corporation Information
6.8.2 Tyco Healthcare Description and Business Overview
6.8.3 Tyco Healthcare Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Tyco Healthcare Iodine-containing Contrast Medium Product Portfolio
6.8.5 Tyco Healthcare Recent Developments/Updates
6.9 Imax
6.9.1 Imax Corporation Information
6.9.2 Imax Description and Business Overview
6.9.3 Imax Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Imax Iodine-containing Contrast Medium Product Portfolio
6.9.5 Imax Recent Developments/Updates
6.10 Takeda
6.10.1 Takeda Corporation Information
6.10.2 Takeda Description and Business Overview
6.10.3 Takeda Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Takeda Iodine-containing Contrast Medium Product Portfolio
6.10.5 Takeda Recent Developments/Updates
6.11 Fuji Pharma
6.11.1 Fuji Pharma Corporation Information
6.11.2 Fuji Pharma Iodine-containing Contrast Medium Description and Business Overview
6.11.3 Fuji Pharma Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Fuji Pharma Iodine-containing Contrast Medium Product Portfolio
6.11.5 Fuji Pharma Recent Developments/Updates
6.12 Towaseiyaku
6.12.1 Towaseiyaku Corporation Information
6.12.2 Towaseiyaku Iodine-containing Contrast Medium Description and Business Overview
6.12.3 Towaseiyaku Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Towaseiyaku Iodine-containing Contrast Medium Product Portfolio
6.12.5 Towaseiyaku Recent Developments/Updates
6.13 Hikari Pharmaceutical
6.13.1 Hikari Pharmaceutical Corporation Information
6.13.2 Hikari Pharmaceutical Iodine-containing Contrast Medium Description and Business Overview
6.13.3 Hikari Pharmaceutical Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Hikari Pharmaceutical Iodine-containing Contrast Medium Product Portfolio
6.13.5 Hikari Pharmaceutical Recent Developments/Updates
6.14 Consentis Diagnostics GmbH
6.14.1 Consentis Diagnostics GmbH Corporation Information
6.14.2 Consentis Diagnostics GmbH Iodine-containing Contrast Medium Description and Business Overview
6.14.3 Consentis Diagnostics GmbH Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Consentis Diagnostics GmbH Iodine-containing Contrast Medium Product Portfolio
6.14.5 Consentis Diagnostics GmbH Recent Developments/Updates
6.15 T2Pharma
6.15.1 T2Pharma Corporation Information
6.15.2 T2Pharma Iodine-containing Contrast Medium Description and Business Overview
6.15.3 T2Pharma Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.15.4 T2Pharma Iodine-containing Contrast Medium Product Portfolio
6.15.5 T2Pharma Recent Developments/Updates
6.16 YRPG
6.16.1 YRPG Corporation Information
6.16.2 YRPG Iodine-containing Contrast Medium Description and Business Overview
6.16.3 YRPG Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.16.4 YRPG Iodine-containing Contrast Medium Product Portfolio
6.16.5 YRPG Recent Developments/Updates
6.17 BeiLu Pharma
6.17.1 BeiLu Pharma Corporation Information
6.17.2 BeiLu Pharma Iodine-containing Contrast Medium Description and Business Overview
6.17.3 BeiLu Pharma Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.17.4 BeiLu Pharma Iodine-containing Contrast Medium Product Portfolio
6.17.5 BeiLu Pharma Recent Developments/Updates
6.18 Grupo Juste
6.18.1 Grupo Juste Corporation Information
6.18.2 Grupo Juste Iodine-containing Contrast Medium Description and Business Overview
6.18.3 Grupo Juste Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Grupo Juste Iodine-containing Contrast Medium Product Portfolio
6.18.5 Grupo Juste Recent Developments/Updates
6.19 Daiichi Sankyo
6.19.1 Daiichi Sankyo Corporation Information
6.19.2 Daiichi Sankyo Iodine-containing Contrast Medium Description and Business Overview
6.19.3 Daiichi Sankyo Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Daiichi Sankyo Iodine-containing Contrast Medium Product Portfolio
6.19.5 Daiichi Sankyo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Iodine-containing Contrast Medium Industry Chain Analysis
7.2 Iodine-containing Contrast Medium Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Iodine-containing Contrast Medium Production Mode & Process
7.4 Iodine-containing Contrast Medium Sales and Marketing
7.4.1 Iodine-containing Contrast Medium Sales Channels
7.4.2 Iodine-containing Contrast Medium Distributors
7.5 Iodine-containing Contrast Medium Customers
8 Iodine-containing Contrast Medium Market Dynamics
8.1 Iodine-containing Contrast Medium Industry Trends
8.2 Iodine-containing Contrast Medium Market Drivers
8.3 Iodine-containing Contrast Medium Market Challenges
8.4 Iodine-containing Contrast Medium Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
| ※参考情報 ヨウ素含有造影剤は、医療の中で非常に重要な役割を果たしている物質です。特に放射線画像診断や血管造影などで用いられ、診断精度の向上に寄与しています。これらの造影剤は、主にヨウ素という元素を含んでおり、人体内での放射線吸収率が高いため、画像上でのコントラストが明確になります。 まず、ヨウ素含有造影剤の定義について考えましょう。造影剤は、体内の特定の組織や器官を際立たせるために使用される薬剤であり、その中でヨウ素が重要な役割を果たしています。具体的には、X線やCTスキャン、MRIなどの画像診断手技の際に、対象となる部位を明確に映し出すために使用されます。ヨウ素はX線に対する高い吸収特性を持っているため、造影剤に含まれることで、画像上でより明瞭に描出されるのです。 次に、ヨウ素含有造影剤の特徴を見ていきましょう。この造影剤の主な特徴は、高い放射線吸収能力に加え、体内で比較的安定して存在できる点です。また、造影剤は水溶性であり、血液循環に容易に取り込まれ、対象部位に到達するのが迅速です。しかし、このような特性がある一方で、アレルギー反応を引き起こす可能性があるため、患者に対する事前の問診が重要です。 ヨウ素含有造影剤には、主に2つの種類が存在します。ひとつは、「非イオン性造影剤」で、もうひとつは「イオン性造影剤」です。非イオン性造影剤は、一般的には副作用が少なく、患者に対する安全性が高いとされています。これに対し、イオン性造影剤は、腎機能が低下している患者には使用が制限されることが多いです。新しい非イオン性造影剤は、より高い浸透性を持ち、患者の快適性を向上させる効果があります。 用途については、ヨウ素含有造影剤は非常に多岐にわたります。CTスキャンにおける画像診断で広く使用されており、特に腫瘍の検出や内部の血管の異常を評価する際に重要です。また、血管造影検査においては、冠動脈や脳血管などの細かい血管の状態を観察するために不可欠です。さらに、消化器官の検査においても、消化管の状態を観察するために用いられます。 関連技術としては、近年の医療技術進歩に伴い、ヨウ素含有造影剤と連携する技術も発展しています。例えば、3D画像再構築技術やPET-CTなど、より詳細な診断が可能な手法が普及しています。これにより、従来の2D画像では捉えきれなかった情報を提供し、より精度の高い診断が可能になっています。さらに、造影剤の投与方法も注目されており、経口や静脈内投与のほか、特定の条件下での局所的な投与など、さまざまなアプローチが模索されています。 最後に、ヨウ素含有造影剤の使用に際しては、副作用やアレルギー反応に対する注意が必要です。特に、過去に造影剤に対するアレルギー反応を経験した患者については、事前に適切な評価を行うことが求められます。また、腎機能に影響を与える可能性があるため、造影剤を使用する前には腎機能の評価が重要です。これらの注意点を踏まえることで、ヨウ素含有造影剤を安全に使用し、最良の診断結果を得ることが可能になります。 このように、ヨウ素含有造影剤は医療における診断手技を支える重要な要素であり、その正しい理解と適切な使用が求められています。医療従事者は、この造影剤の特性や取扱いについて常に最新の情報を持ち、患者の安全を確保するために努めることが必要です。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
